A contemporary update on pathology reporting for urinary bladder cancer.
Providing the best management for patients with bladder cancer relies on close cooperation among uro-oncologists and pathologists. The pathologist is involved in the diagnosis and assessment of prognostic and therapeutic factors in bladder biopsies, transurethral resection (TUR) and cystectomy specimens. The pathologist must report accurately the key features using terms that are well understood by clinicians. Adequate clinical information is important to pathologists in deciding the best approach in handling and processing the surgical specimens.
Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.
R
R
Mazzucchelli
M
M
Scarpelli
A
A
Lopez-Beltran
L
L
Cheng
R
R
Di Primio
R
R
Montironi
D001706:Biopsy; D001808:Blood Vessels / Q000473:pathology; D057189:Checklist; D015653:Cystectomy; D003661:Decision Support Techniques; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D008297:Male; D060787:Neoplasm Grading; D009361:Neoplasm Invasiveness; D011237:Predictive Value of Tests; D011379:Prognosis; D011467:Prostate / Q000473:pathology; D013048:Specimen Handling; D001749:Urinary Bladder Neoplasms / Q000473:pathology* / Q000601:surgery